- Advanced search
- Immuno Portal
- Malaria Portal
Synonyms: Byfavo® | CNS-7056 | CNS7056
remimazolam is an approved drug (FDA (2020), EMA (2021))
Compound class: Synthetic organic
Comment: Remimazolam is a benzodiazepine type compound, that was developed as an ultra-short-acting sedative/anesthetic [3-4]. This compound combines the actions of the opioid analgesic remifentanil with that of the currently used sedative midazolam (GABAA receptor modulator). Remimazolam is proposed as a safer alternative to the current standard of care.